[1]
S. Ogawa, J. Sato, R. Tanaka, T. Sakakibara, and M. Shino, “Hyponatremia timing, incidence, and associated risk factors in patients treated with cisplatin for lung cancer: a retrospective study”, J Popl Ther Clin Pharmacol, vol. 29, no. 04, pp. 1–10, Dec. 2022.